UZIEL, Tamar,LEVERSON, Joel D.,PAPPANO, William N.,MAGANBHAI HARIBHAI, Dipica B.,MATHEW, Rebecca,KOHLHAPP, Fred,DONAWHO, Cherrie K.
申请号:
AU2019221672
公开号:
AU2019221672A1
申请日:
2019.02.15
申请国别(地区):
AU
年份:
2020
代理人:
摘要:
This invention pertains to a method for the treatment of cancer in a subject comprising administering to the subject an effective amount of a selective BCL-2 inhibitor or a prodrug or pharmaceutically acceptable salt thereof in combination with an effective amount of an anti-PD- 1 antibody or an anti-PD-L1 antibody.